ZHE JIANG DAYANG BIOTECH GROUP CO., LTD.

Zhe Jiang Dayang Biotech Group Co., Ltd.

003017

CNE100004736

Commodity Chemicals

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 31/05/2024 am IST			5-day change	1st Jan Change
17.91 ^CNY	-0.22%		-1.16%	-26.36%

22/05	Zhe Jiang Dayang Biotech Group Co., Ltd. Approves Cash Dividend for the Year 2023	CI
28/04	Zhejiang Xinzhichun Semiconductor Materials Co., Ltd. announced that it has received CNY 14.7143 million in funding from Zhe Jiang Dayang Biotech Group Co., Ltd.	CI

Tranche Update on Zhe Jiang Dayang Biotech Group Co., Ltd.'s Equity Buyback Plan announced on February 6, 2024.

April 02, 2024 at 09:30 pm IST

From February 2, 2024 to March 31, 2024, the company has repurchased 2,253,500 shares, for CNY 34.62 million. With this, the company has completed the repurchase of 2,253,500 shares, for CNY 34.62 million under the buyback announced on February 6, 2024.

Latest news about Zhe Jiang Dayang Biotech Group Co., Ltd.

Zhe Jiang Dayang Biotech Group Co., Ltd. Approves Cash Dividend for the Year 2023	22/05	CI
Zhejiang Xinzhichun Semiconductor Materials Co., Ltd. announced that it has received CNY 14.7143 million in funding from Zhe Jiang Dayang Biotech Group Co., Ltd.	28/04	CI
Zhe Jiang Dayang Biotech Group Co., Ltd. Proposes Final Cash Dividend for 2023	27/04	CI
Tranche Update on Zhe Jiang Dayang Biotech Group Co., Ltd.'s Equity Buyback Plan announced on February 6, 2024.	02/04	CI
Zhe Jiang Dayang Biotech Group Co., Ltd. announces an Equity Buyback for CNY 84 million worth of its shares.	05/02	CI
Zhe Jiang Dayang Biotech Group Co., Ltd. authorizes a Buyback Plan.	02/02	CI
Zhejiang Dayang Biotech Group Co., Ltd. Approves Interim Cash Dividend for the Year 2023, Payable on November 14, 2023	09/11	CI
Certain A Shares of Zhejiang Dayang Biology Technology Co.,Ltd. are subject to a Lock-Up Agreement Ending on 27-OCT-2023.	27/23/27	CI
Zhejiang Dayang Biotech Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23/23/23	CI
Zhejiang Dayang Biotech Group Co., Ltd. Approves Interim Cash Dividend for the Year 2023	21/23/21	CI
Zhejiang Dayang Biotech Group Co., Ltd. Announces the Profit Distribution Proposal for the First Half of 2023	31/23/31	CI
Zhejiang Dayang Biotech Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	29/23/29	CI
Fujian Shunyue Technology Co., Ltd. announced that it expects to receive CNY 96.672753 million in funding from Zhe Jiang Dayang Biotech Group Co., Ltd.	28/23/28	CI
Zhejiang Dayang Biology Technology Co.,Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date Is 29 June 2023	21/23/21	CI
Dayang Biotech Vice Chairman Dies of Illness	22/23/22	MT
Zhejiang Dayang Biology Technology Co.,Ltd. Approves Cash Dividend for the Year 2022	17/23/17	CI
Zhejiang Dayang Biology Technology Co.,Ltd. Proposes Cash Profit Distribution for 2022	26/23/26	CI
Zhejiang Dayang Biotech Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	24/23/24	CI
Zhejiang Dayang Biotech Sells Idle Properties	27/22/27	MT
Zhejiang Dayang Biology Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	23/22/23	CI
Zhejiang Dayang Biology Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	21/22/21	CI
Zhejiang Dayang Biology Technology Co.,Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on July 08, 2022	02/22/02	CI
Tranche Update on Zhejiang Dayang Biology Technology Co.,Ltd.'s Equity Buyback Plan announced on November 26, 2021.	16/22/16	CI
Zhejiang Dayang Biology Technology Co.,Ltd.'s Equity Buyback announced on November 26, 2021, has expired with 2,800,000 shares, representing 4.7% for CNY 88.09 million.	14/22/14	CI
Zhejiang Dayang Biology Technology Co.,Ltd. Approves Final Cash Dividend for the Year 2021	13/22/13	CI

Chart Zhe Jiang Dayang Biotech Group Co., Ltd.

Duration

Period

Chart Zhe Jiang Dayang Biotech Group Co., Ltd.

More charts

Company Profile

Zhejiang Dayang Biotech Group Co Ltd is a China-based company mainly engaged in the production and sales of chemical raw materials such as inorganic salts and veterinary raw materials. The Company's main products include potassium carbonate, potassium bicarbonate, amproline hydrochloride, 2-chloro-6-fluorobenzaldehyde, etc. Its products are used in food, pesticide, fertilizer, medicine and glass fields. The Company conducts its businesses within the Chinese market and to overseas markets.

Sector

Commodity Chemicals

Calendar

16/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Commodity Chemicals

	1st Jan change	Capi.
ZHE JIANG DAYANG BIOTECH GROUP CO., LTD.	-26.36%	20Cr
AIR LIQUIDE	+2.46%	10TCr
SABIC	-8.98%	6.08TCr
PT CHANDRA ASRI PACIFIC TBK	+74.76%	4.89TCr
WANHUA CHEMICAL GROUP CO., LTD.	+13.97%	3.8TCr
LYONDELLBASELL INDUSTRIES N.V.	+4.56%	3.24TCr
WESTLAKE CORPORATION	+14.72%	2.06TCr
NINGXIA BAOFENG ENERGY GROUP CO., LTD.	+11.17%	1.66TCr
HENGLI PETROCHEMICAL CO.,LTD.	+8.81%	1.39TCr
RONGSHENG PETROCHEMICAL CO., LTD.	-3.19%	1.32TCr